Overall, compared to a recently published NNMT review [145,146], this article systematically sorted out the mechanism of NNMT regulating immune escape in liver cancer through metabolic reprogramming for the first time, and proposed its potential as a target for combination therapy. The gene discussed is NNMT; the disease is liver cancer.